medigraphic.com
ISSN 0035-0052 (Print)

2007, Number 1

<< Back Next >>

Rev Mex Pediatr 2007; 74 (1)

Clinical features of atypical kawasaki cases in a children´s hospital of high specialization

Coria LJJ, Cervantes PV, Urtiz JF, Reyes LA, Coria GJA

Language: Spanish
References: 12
Page: 9-15
PDF size: 63.61 Kb.


ABSTRACT

Objective. To identify the clinical manifestations and of the complementary studies in children with diagnostic of atypical Kawasaki assisted in the hospital.
Material and methods. The clinical files of 22 patients (11 children and 11 girls) with diagnostic of atypical Kawasaki were revised. Data about clinical manifestations, laboratory studies, electrocardiographic (ECG) and echocardiographic findings, complications, clinical evolution and ECG changes for one year, starting from the application of intravenous gammaglobulina (IVGG).
Results. Presence of lips lesions prevailed in all of them, conjunctivitis, pharyngeal eritema and language “strawberry”. Thirteen had coronary ectasia and four of them developed aneurysm. Two of the children received a second dose of IVGG. The resolution of the fever coincided with positive changes in the laboratory exams and the ECG and echocardiographic, in the first three months.
Conclusions. It is necessary, in these children that before the suspicion of heart anomaly studies are made and of being confirmed anomalies of the coronary ones to begin their treatment.


REFERENCES

  1. Kawasaki T. Febricula oculo-oro cutaneous acrodesquimatous, syndrome with or without acute non-supurative cervical lymphadenitis in infancy and childhood: clinical observations of 50 cases. Allergy 1967; 16: 178-222.

  2. Rodríguez SR. Síndrome linfomucocutáneo. Bol Med Hosp Infant Mex 1977; 34: 53-7.

  3. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [in Japanese]. Arerugi 1967; 16: 178.

  4. King J, Schlieper A, Birdi N, Cappelli M, Korneluk Y. The effect of Kawasaki disease on cognition and behavior. Arch Pediatr Adolesc Med 2000; 154: 463-468.

  5. Mason W, Takahasi M. Kawasaky syndrome. CID 1999; 28: 169-87.

  6. Rowley AH. Incomplete (Atypical) Kawasaki disease. Pediatr Infect Dis J. Concise Review of Pediatrica Infectious Diseases. 2002: 563-5.

  7. Newburger WJ, Takahashi M, Gerber AM, Gewitz HM, Tani Y Ll, Burns CJ, Shulman TS et al. Diagnosis, treatment, and long-term management of Kawasaki disease. A statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, Council on cardiovascular disease in the young, American Heart Association. Circulation 2004; 110: 2747-71.

  8. Barone S, Ponterlli S, Krilov R. The differentiation of classic Kawasaki disease, atipical Kawasaki disease, and acute adenoviral infection. Arch Pediatr Adolesc Med 2000; 154: 453-6.

  9. Sengler C, Gaedicke G. Pulmonary symptoms in Kawasaki disease. The Pediatric Infectious Disease Journal 2004; 23: 782-4.

  10. Kleiman MB, Passo MH. Incomplete Kawasaki disease with facial nerve paralysis and coronary artery involvement (letter). Pediatr Infect Dis J 1998; 7: 301-2.

  11. Burns JC, Wiggins JW Jr, Toews WH, Newburger JW, Leung DYM, Wilson H, Glodé MP. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr 1986; 109: 759-63.

  12. Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less tjhan one year of age. J Pediatr 1995; 126(4): 524.-29.




2020     |     www.medigraphic.com